Syndax Debt Ratio from 2010 to 2025

SNDX Stock

USD 13.71 0.39 2.77%

Syndax Pharmaceuticals Debt Ratio yearly trend continues to be fairly stable with very little volatility. Debt Ratio will likely drop to 0.02 in 2025. During the period from 2010 to 2025, Syndax Pharmaceuticals Debt Ratio regression line of annual values had r-squared of 0.30 and arithmetic mean of 1.54. View All Fundamentals

Debt Ratio

First Reported

2010-12-31

Previous Quarter

0.01671597

Current Value

0.0159

Quarterly Volatility

3.62361897

Credit Downgrade

Yuan Drop

Covid

Check Syndax Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Syndax Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 7.6 K, Interest Expense of 5.2 M or Selling General Administrative of 126.9 M, as well as many indicators such as Price To Sales Ratio of 52.11, Dividend Yield of 0.0198 or PTB Ratio of 4.12. Syndax financial statements analysis is a perfect complement when working with Syndax Pharmaceuticals Valuation or Volatility modules.

Check out the analysis of Syndax Pharmaceuticals Correlation against competitors.

For more information on how to buy Syndax Stock please use our How to Invest in Syndax Pharmaceuticals guide.

Latest Syndax Pharmaceuticals' Debt Ratio Growth Pattern

Below is the plot of the Debt Ratio of Syndax Pharmaceuticals over the last few years. It is Syndax Pharmaceuticals' Debt Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Syndax Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.

Debt Ratio

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Debt Ratio

Timeline

Syndax Debt Ratio Regression Statistics

	Arithmetic Mean	1.54
	Geometric Mean	0.07
	Coefficient Of Variation	235.62
	Mean Deviation	2.20
	Median	0.02
	Standard Deviation	3.62
	Sample Variance	13.13
	Range	14.1321
	R-Value	(0.55)
	Mean Square Error	9.81
	R-Squared	0.30
	Significance	0.03
	Slope	(0.42)
	Total Sum of Squares	196.96

Syndax Debt Ratio History

	2025	0.0159
	2024	0.0167
	2023	0.002668
	2022	0.002335
	2021	0.0466
	2020	0.0683

Other Fundumenentals of Syndax Pharmaceuticals

Cash Flow To Debt Ratio

Syndax Pharmaceuticals Debt Ratio component correlations

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Short Term Investments	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Net Tangible Assets	Long Term Debt	Net Receivables	Deferred Long Term Liab	Short Long Term Debt	Property Plant Equipment	Capital Surpluse	Net Invested Capital	Long Term Investments	Net Working Capital	Capital Stock	Long Term Debt Total
Total Assets		0.82	0.93	-0.83	-0.95	0.92	0.97	0.75	0.99	-0.28	0.99	0.95	0.9	0.81	0.72	0.96	0.82	0.87	0.92	0.77	0.91	0.95	0.91
Total Stockholder Equity	0.82		0.72	-0.89	-0.71	0.65	0.8	0.23	0.87	-0.58	0.82	0.85	0.68	0.35	0.66	0.82	0.62	0.91	0.88	0.27	0.93	0.88	0.66
Current Deferred Revenue	0.93	0.72		-0.69	-0.88	0.86	0.93	0.74	0.91	-0.15	0.92	0.84	0.99	0.84	0.54	0.94	0.86	0.76	0.87	0.79	0.85	0.89	0.91
Net Debt	-0.83	-0.89	-0.69		0.77	-0.78	-0.72	-0.38	-0.87	0.48	-0.83	-0.82	-0.64	-0.39	-0.65	-0.81	-0.62	-0.83	-0.84	-0.43	-0.86	-0.84	-0.68
Retained Earnings	-0.95	-0.71	-0.88	0.77		-0.95	-0.92	-0.8	-0.94	0.29	-0.96	-0.92	-0.88	-0.83	-0.81	-0.88	-0.9	-0.82	-0.82	-0.81	-0.78	-0.9	-0.88
Accounts Payable	0.92	0.65	0.86	-0.78	-0.95		0.85	0.8	0.89	-0.24	0.93	0.86	0.85	0.8	0.72	0.87	0.9	0.75	0.78	0.83	0.75	0.86	0.86
Short Term Investments	0.97	0.8	0.93	-0.72	-0.92	0.85		0.72	0.97	-0.29	0.96	0.94	0.92	0.82	0.72	0.94	0.83	0.85	0.89	0.73	0.88	0.92	0.89
Total Liab	0.75	0.23	0.74	-0.38	-0.8	0.8	0.72		0.68	0.19	0.72	0.62	0.75	0.97	0.46	0.68	0.67	0.46	0.56	0.99	0.49	0.61	0.81
Total Current Assets	0.99	0.87	0.91	-0.87	-0.94	0.89	0.97	0.68		-0.34	0.99	0.96	0.88	0.75	0.74	0.96	0.8	0.9	0.93	0.7	0.93	0.96	0.88
Short Term Debt	-0.28	-0.58	-0.15	0.48	0.29	-0.24	-0.29	0.19	-0.34		-0.31	-0.34	-0.12	0.1	-0.41	-0.27	-0.29	-0.43	-0.3	0.17	-0.35	-0.35	-0.11
Common Stock	0.99	0.82	0.92	-0.83	-0.96	0.93	0.96	0.72	0.99	-0.31		0.97	0.9	0.78	0.76	0.95	0.86	0.89	0.9	0.74	0.9	0.96	0.89
Net Tangible Assets	0.95	0.85	0.84	-0.82	-0.92	0.86	0.94	0.62	0.96	-0.34	0.97		0.82	0.69	0.86	0.91	0.82	0.89	0.87	0.63	0.87	0.91	0.83
Long Term Debt	0.9	0.68	0.99	-0.64	-0.88	0.85	0.92	0.75	0.88	-0.12	0.9	0.82		0.85	0.56	0.89	0.88	0.72	0.83	0.8	0.8	0.86	0.87
Net Receivables	0.81	0.35	0.84	-0.39	-0.83	0.8	0.82	0.97	0.75	0.1	0.78	0.69	0.85		0.49	0.77	0.75	0.53	0.64	0.97	0.57	0.69	0.86
Deferred Long Term Liab	0.72	0.66	0.54	-0.65	-0.81	0.72	0.72	0.46	0.74	-0.41	0.76	0.86	0.56	0.49		0.64	0.75	0.7	0.55	0.43	0.55	0.66	0.56
Short Long Term Debt	0.96	0.82	0.94	-0.81	-0.88	0.87	0.94	0.68	0.96	-0.27	0.95	0.91	0.89	0.77	0.64		0.8	0.85	0.91	0.71	0.91	0.92	0.92
Property Plant Equipment	0.82	0.62	0.86	-0.62	-0.9	0.9	0.83	0.67	0.8	-0.29	0.86	0.82	0.88	0.75	0.75	0.8		0.69	0.68	0.7	0.65	0.8	0.77
Capital Surpluse	0.87	0.91	0.76	-0.83	-0.82	0.75	0.85	0.46	0.9	-0.43	0.89	0.89	0.72	0.53	0.7	0.85	0.69		0.94	0.46	0.94	0.96	0.82
Net Invested Capital	0.92	0.88	0.87	-0.84	-0.82	0.78	0.89	0.56	0.93	-0.3	0.9	0.87	0.83	0.64	0.55	0.91	0.68	0.94		0.6	0.99	0.98	0.9
Long Term Investments	0.77	0.27	0.79	-0.43	-0.81	0.83	0.73	0.99	0.7	0.17	0.74	0.63	0.8	0.97	0.43	0.71	0.7	0.46	0.6		0.52	0.64	0.83
Net Working Capital	0.91	0.93	0.85	-0.86	-0.78	0.75	0.88	0.49	0.93	-0.35	0.9	0.87	0.8	0.57	0.55	0.91	0.65	0.94	0.99	0.52		0.96	0.85
Capital Stock	0.95	0.88	0.89	-0.84	-0.9	0.86	0.92	0.61	0.96	-0.35	0.96	0.91	0.86	0.69	0.66	0.92	0.8	0.96	0.98	0.64	0.96		0.9
Long Term Debt Total	0.91	0.66	0.91	-0.68	-0.88	0.86	0.89	0.81	0.88	-0.11	0.89	0.83	0.87	0.86	0.56	0.92	0.77	0.82	0.9	0.83	0.85	0.9

Click cells to compare fundamentals

About Syndax Pharmaceuticals Financial Statements

Syndax Pharmaceuticals investors use historical fundamental indicators, such as Syndax Pharmaceuticals' Debt Ratio, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Syndax Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Debt Ratio	0.02	0.02
Cash Flow To Debt Ratio	(22.69)	(23.82)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

Additional Tools for Syndax Stock Analysis

When running Syndax Pharmaceuticals' price analysis, check to measure Syndax Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Syndax Pharmaceuticals is operating at the current time. Most of Syndax Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Syndax Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Syndax Pharmaceuticals' price. Additionally, you may evaluate how the addition of Syndax Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Syndax Debt Ratio from 2010 to 2025

Latest Syndax Pharmaceuticals' Debt Ratio Growth Pattern

Syndax Debt Ratio Regression Statistics

Syndax Debt Ratio History

Other Fundumenentals of Syndax Pharmaceuticals

Syndax Pharmaceuticals Debt Ratio component correlations

About Syndax Pharmaceuticals Financial Statements

Also Currently Popular

Additional Tools for Syndax Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY